CA2589898A1 - Modulation de l'ovulation - Google Patents

Modulation de l'ovulation Download PDF

Info

Publication number
CA2589898A1
CA2589898A1 CA002589898A CA2589898A CA2589898A1 CA 2589898 A1 CA2589898 A1 CA 2589898A1 CA 002589898 A CA002589898 A CA 002589898A CA 2589898 A CA2589898 A CA 2589898A CA 2589898 A1 CA2589898 A1 CA 2589898A1
Authority
CA
Canada
Prior art keywords
seq
gdf
ovulation
fragment
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002589898A
Other languages
English (en)
Inventor
Jennifer Lee Juengel
Kenneth Pattrick Mcnatty
Lloyd Gary Moore
Robert Syndecombe Bower
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AgResearch Ltd
Original Assignee
AgResearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ53694304A external-priority patent/NZ536943A/en
Application filed by AgResearch Ltd filed Critical AgResearch Ltd
Publication of CA2589898A1 publication Critical patent/CA2589898A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002589898A 2004-12-02 2005-12-02 Modulation de l'ovulation Abandoned CA2589898A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
NZ53694304A NZ536943A (en) 2004-12-02 2004-12-02 Modulation of ovulation
NZ536943 2004-12-02
NZ539039 2005-03-24
NZ53903905 2005-03-24
NZ54117005 2005-07-08
NZ541170 2005-07-08
PCT/NZ2005/000313 WO2006059913A1 (fr) 2004-12-02 2005-12-02 Modulation de l'ovulation

Publications (1)

Publication Number Publication Date
CA2589898A1 true CA2589898A1 (fr) 2006-06-08

Family

ID=36565307

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002589898A Abandoned CA2589898A1 (fr) 2004-12-02 2005-12-02 Modulation de l'ovulation

Country Status (6)

Country Link
EP (1) EP1819722A4 (fr)
JP (1) JP2008521891A (fr)
AU (1) AU2005310356A1 (fr)
BR (1) BRPI0518809A2 (fr)
CA (1) CA2589898A1 (fr)
WO (1) WO2006059913A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006130022A1 (fr) * 2005-05-30 2006-12-07 Agresearch Limited Modulation de l'ovulation au moyen d'agonistes et d'antagonistes de bmprii
CA2615006A1 (fr) 2005-07-18 2007-01-25 Adelaide Research And Innovation Pty Ltd Modulation de l'apoptose des cellules de la granulosa
BRPI0706173C1 (pt) * 2007-11-23 2011-02-22 Brasil Pesquisa Agropec metodo para identificação massal de animais com aumento na prolificidade
JP7340866B2 (ja) * 2018-05-09 2023-09-08 モナッシュ ユニバーシティ 妊孕性を高めるための薬剤及び方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821056A (en) * 1993-01-12 1998-10-13 The Johns Hopkins University School Of Medicine Growth differentiation factor-9
US6030617A (en) * 1993-01-12 2000-02-29 The Johns Hopkins University School Of Medicine Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate

Also Published As

Publication number Publication date
BRPI0518809A2 (pt) 2008-12-09
WO2006059913A1 (fr) 2006-06-08
EP1819722A1 (fr) 2007-08-22
EP1819722A4 (fr) 2009-09-09
JP2008521891A (ja) 2008-06-26
AU2005310356A1 (en) 2006-06-08
WO2006059913A9 (fr) 2008-05-22

Similar Documents

Publication Publication Date Title
EP1626055B1 (fr) Analogues de GnRH non mammifère et leur utilisation pour la régulation du système immunitaire
CN101522707B (zh) 肌肉生长抑制素拮抗剂
Ando et al. Thyrotropin receptor antibodies: new insights into their actions and clinical relevance
US20050272028A1 (en) Myostatin and mimetics thereof
US20060047107A1 (en) Cortistatin: neuropeptides, compositions and methods
CN110036024A (zh) 肌肉性能改善化合物
CA2589898A1 (fr) Modulation de l'ovulation
CA1330420C (fr) Preparations contenant des fragments peptidiques de l'hormone de croissance
Robert et al. The recognition of hypothalamo‐neurohypophysial functions by developing T cells
ES2259458T3 (es) Persefina humana.
CN110636855A (zh) 人pd1肽疫苗及其用途
JP2010155843A (ja) 骨発生の調節方法
AU2002230466B2 (en) Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
NZ536943A (en) Modulation of ovulation
US20090304698A1 (en) Modulation of ovulation
RU2270862C2 (ru) Нуклеотидные и аминокислотные последовательности факторов яйцеклеток для изменения роста яичниковых фолликулов in vivo или in vitro
EP1819726A1 (fr) Modulation de l'ovulation
KR20160101906A (ko) 당단백질 호르몬의 장시간-작용하는 초작용제
EP0303488B1 (fr) Molécules biologiquement actives
JP2001333772A (ja) 可変性の活性を有する単鎖稔性ホルモン
WO2006130022A1 (fr) Modulation de l'ovulation au moyen d'agonistes et d'antagonistes de bmprii
CN101120014A (zh) 调节排卵
AU2002317634B2 (en) Modulation of insulin-regulated aminopeptidase (IRAP)/Angiotensin IV (AT4) receptor activity
Cook Mutational analysis of the activin and inhibin subunits and the potential for receptor interactions
Hasegawa et al. Evaluation of the contraceptive potential of recombinant proteins and synthetic peptides of zona pellucida (ZP)

Legal Events

Date Code Title Description
FZDE Dead